Minerva Neurosciences Inc... (NERV)
NASDAQ: NERV
· Real-Time Price · USD
2.26
0.46 (25.91%)
At close: Aug 15, 2025, 3:59 PM
2.32
2.85%
After-hours: Aug 15, 2025, 07:47 PM EDT
Minerva Neurosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 5,710.9B | 5,710.9B | -32.73M | -30.68M | -29.09M | -26.79M | -26.79M | -29.31M | -32.11M | -46.69M | -48.99M | -50.87M | -49.91M | -35.92M | -34.83M | 5.29M |
Depreciation & Amortization | 22.47K | 28.86K | 30.98K | 30.98K | 30.98K | 29.62K | 24K | 16.26K | 8.51K | 101.69M | 101.7M | 101.74M | 101.79M | 146.38K | 176.36K | 176.19K |
Stock-Based Compensation | 1.33M | 1.69M | 1.75M | 2.03M | 1.97M | 2.31M | 2.97M | 3.43M | 4.11M | 4.37M | 4.44M | 4.76M | 5.22M | 5.98M | 6.92M | 9.02M |
Other Working Capital | -948.27K | 1.06M | 1.67M | -251.94K | 4.1M | 3.59M | -423.98K | -66.42K | -3.18M | -2.99M | -272.03K | 195.38K | -598.27K | -2.22M | -1.8M | -43.72M |
Other Non-Cash Items | -20,094.7B | -20,094.7B | 7.6M | 6.37M | 5.27M | 12.83M | 7.81M | 7.61M | 7.41M | -79.27M | -79.46M | -79.67M | -80.16M | -45.64B | -45.64B | -45.64B |
Deferred Income Tax | n/a | 7.83M | n/a | n/a | n/a | -7.83M | n/a | n/a | n/a | -1.8M | -1.8M | -1.8M | -1.8M | 45.64B | 45.64B | 45.64B |
Change in Working Capital | -1.15M | 222.11K | 2.2M | 222.63K | 4.94M | 4.45M | -1.65M | -691.59K | -4.06M | -3.66M | -346K | 651.92K | 259.33K | -1.72M | -3.34M | -45.6M |
Operating Cash Flow | -14,383.8B | -14,383.8B | -22.92M | -22.86M | -16.88M | -15M | -17.63M | -18.95M | -24.65M | -25.37M | -24.46M | -25.19M | -24.6M | -26.93M | -28.17M | -29.84M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | 2.13K | 2.13K | 2.13K | 2.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.87B | -3.87B | -3.87B |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 28.37B | 28.37B | 28.38B |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -16.33K | -18.45K | -18.45K | -18.45K | -2.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -16.33K | -14.2K | -14.2K | -14.2K | 2.13K | n/a | n/a | n/a | 24.5B | 24.51B | 24.51B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -415.9M | -415.98M | -396.29M | -396.29M | 19.6M | 19.69M | -10 | -10 | 59.94B | 59.94B | 59.94B | 60B | 742.12M | 741.89M | 747.19M |
Financial Cash Flow | n/a | 19.58B | 19.58B | 19.6B | 19.6B | 19.6M | 19.69M | -10 | -10 | 59.94B | 59.94B | 59.94B | 60B | 13.28B | 13.29B | 13.3B |
Net Cash Flow | -19.55M | -20.38M | -74.82M | -55.06M | -49.09M | -47.22M | 2.04M | -18.97M | -24.66M | -25.37M | -24.46M | -25.19M | 35.4M | 33.07M | 41.96M | 50.1M |
Free Cash Flow | -14,383.8B | -14,383.8B | -22.92M | -22.86M | -16.88M | -15.01M | -17.65M | -18.97M | -24.66M | -25.37M | -24.46M | -25.19M | -24.6M | -26.93M | -28.17M | -29.84M |